Cellumed Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,975
15,375
11,981
37,493
9,605
Depreciation, Depletion & Amortization
3,172
3,158
3,607
3,414
3,095
Other Funds
1,055
1,676
2,454
8,605
7,794
Funds from Operations
3,957
5,143
4,505
6,147
1,802
Changes in Working Capital
3,595
715
112
1,868
6,370
Net Operating Cash Flow
362
5,857
4,618
4,279
4,568
Capital Expenditures
8,615
3,873
4,846
5,219
4,520
Sale of Fixed Assets & Businesses
192
-
87
31
300
Purchase/Sale of Investments
207
34
8,767
1,436
839
Net Investing Cash Flow
7,592
3,839
13,526
3,752
4,986
Issuance/Reduction of Debt, Net
2,961
1,665
15,765
1,818
1,170
Net Financing Cash Flow
6,626
8,496
21,680
7,689
6,624
Net Change in Cash
603
1,201
3,537
342
2,690
Free Cash Flow
1,062
7,503
5,892
5,851
5,339
Other Sources
1,486
-
-
-
73
Change in Capital Stock
2,611
8,485
3,461
902
-
Exchange Rate Effect
-
-
-
-
241
Other Uses
862
-
-
-
-

About Cellumed Co.

View Profile
Address
Unit 402, Ace Techno Tower 9-cha
Seoul SL 08589
Korea, Republic Of
Employees -
Website http://www.cellumed.co.kr
Updated 09/14/2018
CELLUMED Co., Ltd. engages in the manufacture and distribution of medical device and biomaterials. Its products include holders for operations, biologics, artificial joints, and others. The company was founded in June 1975 and is headquartered in Seoul, South Korea.